TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

305 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicPeptide & GLP-1Mental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

134 studies on the map

Effectiveness of the Diabetes Homeless Medication Support (D-HOMES) Program on Diabetes Management — Hennepin Healthcare Research Institute, MinneapolisCircadian Intervention to Improve Cardiometabolic Health — College of Health Research Complex--University of Utah, Salt Lake CityAcute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis — AdventHealth Translational Research Institute, OrlandoPilot of Continuous Glucose Monitor-Augmented Food Is Medicine — University of North Carolina at Chapel Hill, Chapel HillHealth Without Barriers/Salud Sin Barreras- Northern Colorado — Colorado State University, Fort CollinsOutcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus — Arizona Kidney Disease and Hypertension Center, PhoenixUsing Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes — Stanford University, StanfordThe CARING Study: Creating and Restoring Health Through Nutrition Guidance — Physicians Committee for Responsible Medicine, Washington D.C.Novel Digital Patient-Reported Outcomes Tool for Diabetes Management — NYU Langone Health, New YorkLiver Transplant CGM — Mount Sinai Hospital, New YorkGLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH — Massachusetts General Hospital, BostonUnderstanding Metabolism and Inflammation Risks for Diabetes in Adolescents — University of Michigan, Ann ArborA Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Clinical Research Institute of Arizona, Sun City WestEffects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function — The Ross Heart Hospital, ColumbusSafety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial — AARA Clinical Research, GlendaleA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — Investigative Site, Beverly HillsEvaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis — National Institutes of Health Clinical Center, BethesdaKetogenic Diet and Diabetes Demonstration Project — University of New Mexico, AlbuquerqueTrial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) — Arizona Clinical Trials - Pecos, ChandlerAssessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions — UT Southwestern Medical Center, DallasMobile App Logging for Diabetes in Pregnancy — Augusta University, AugustaCD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus — Children's Hospital of Philadelphia, PhiladelphiaDietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy — University South Carolina, ColumbiaACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community — Sam Houston State University College of Osteopathic Medicine, ConroeUS Zamto-cel Autoimmune Diseases — Froedtert Hospital and the Medical College of Wisconsin, MilwaukeeDapagliflozin in Active Lupus Nephritis — Massachusetts General Hospital, BostonPolypill for Prevention of Cardiomyopathy — UT Southwestern Medical Center, DallasYouth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study — Children's National Hospital (CNH), Washington D.C.A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Lakeview Clinical Research, GuntersvilleWild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure — Georgia State University, AtlantaA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2) — Inland Rheumatology Clinical Trials, Inc., UplandCulturally Tailored Program for Food-Insecure Adults: SPICE-D — Wake Forest University Health Sciences, Winston-SalemA Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS) — University of Arizona, TucsonA Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease — Research Site 4, Redwood CityDiabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations — Community Health Center of Franklin County, GreenfieldA Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — CenExel Anaheim Clinical Trials, AnaheimA Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 — University of Colorado, Denver, DenverA Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE) — Climb Bio Investigative Site #100104, AllenType 2 Continuous Glucose Monitoring Academy — Children's Hospital Los Angeles, Los AngelesPharmacist-led Continuous Glucose Monitoring — USF Health Department of Family Medicine, TampaSGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia — Texas Diabetes Institute/UH, San AntonioEvaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. — WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus ChristiVirtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy — Rutgers Health Family Medicine at Monument Square, New BrunswickAcute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes — University of Texas Health Science Center at San Antonio, San AntonioA Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) — Wallace & Lee Center, Beverly HillsPrecision Dosing of Metformin in Youth With T2D — UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic, OaklandSystemic Lupus Erythematosus in Gullah Health — Medical University of South Carolina, CharlestonResearch Accelerated by You Lupus Registry — Online Registry - No Physical Site Required, Washington D.C.Cutaneous Lupus Registry — University of Texas Southwestern Medical Center Dallas, DallasA Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) — University of Colorado Anschutz Medical Campus, AuroraA Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants — Local Institution - 0062, MesaA Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers — Royal Research, HollywoodEffect of Sleep Extension on Ceramides in People with Overweight and Obesity — College of Health Research Complex--University of Utah, Salt Lake CityBrief Pain Exposure Therapy (BPET) For Nociplastic Pain — University of Michigan, Ann ArborMaternal Autoimmune Disease Research Alliance (MADRA) Registry — Duke University, DurhamTrial of Belimumab in Early Lupus — Feinstein Institute, ManhassetSafety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes — University of Alabama, BirminghamEfficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus — Lynn Institute of the Ozarks, Little RockThe Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults — Translational Research Institute for Metabolism and Diabetes, OrlandoThe Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study — University of California, San Francisco, San FranciscoJoint Patient and Caregiver Intervention for Older African Americans With Type 2 Diabetes — Medical College of Wisconsin, MilwaukeeA Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — Central Research Associates - Flourish - PPDS, BirminghamMechanism of SGLT2 Inhibition in the Kidney — University of Michigan, Ann ArborA Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease — Wallace Rheumatic Center, Beverly HillsRESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus — University of California Irvine, OrangePhase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). — Pinnacle Research Group Llc, AnnistonImplementing an Effective Diabetes Intervention Among Low-Income Immigrants — NYU Langone Health, New YorkHigh Fructose Diet, the Gut Microbiome, and Metabolic Health — Mount Sinai Morningside, New YorkHP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes — Alliance Clinical Canoga Park (Hope Clinical Research), Canoga ParkRheumatology Diet Study — UCF Health Clinics, OrlandoBAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus — Nationwide Children's, ColumbusThe BRIDGE Pain Study — Cincinnati Children's Hospital, CincinnatiPRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis — Purushotham & Akther Kotha MD, Inc., La MesaPreventing Type 2 Diabetes in Black Emergent Adult — UNC-Chapel Hill, Chapel HillA Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus — Clinical Trial Site, Chula VistaEffects of Stopping Hydroxychloroquine in Elderly Lupus Disease — University of California, Los Angeles, Los AngelesIH, Brain Health, and T2D — University of Iowa, Iowa CityA Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) — GSK Investigational Site, AnnistonA Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE — Research Site, San FranciscoA Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD) — Life Clinical Trials - Colonial Drive - Margate /ID# 276050, MargateNYSCF Scientific Discovery Biobank — New York Stem Cell Foundation Research Institute, New YorkAchieving Routine Intervention and Screening for Emotional Health — University of Chicago, ChicagoA Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment — Alloy Clinical Research LLC, KissimmeeImplementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) — University of Alabama, BirminghamPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets — Central Research Associates, LLC dba Flourish Research, BirminghamBrain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) — Washington University School of Medicine, St LouisPreventing T2DM After GDM With Immediate Postpartum Screening — University of Massachusetts Memorial Medical Center, WorcesterIntervention to Improve Communication and Medication Adherence in Lupus — Duke University, DurhamTransforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus — University of Alabama Birmingham Hospital, BirminghamPhase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy — Central Research Associates, LLC dba Flourish Research, BirminghamGlycemic Excursion Minimization (GEM) to Outshine Health Disparities — Georgia Prevention Institute, AugustaExercise and Intranasal Insulin in Type 2 Diabetes — Robert Wood Johnson University Hospital Clinical Research Center, New BrunswickA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants — Loma Linda University health, Loma LindaREACT-01: Reversing Autoimmunity Through Cell Therapy — Seattle Children's Hospital, SeattleThe Treatment of Painful Diabetic Neuropathy With Diet — AdventHealth Hendersonville, HendersonvilleAlnuctamab for Refractory SLE (LATTE Study) — Icahn School of Medicine at Mount Sinai, New YorkEnhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients — One Robert Wood Johnson Place, New BrunswickGlycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes — University Health - Texas Diabetic Institute, San AntonioImplementation of Team Clinic for Type 2 Diabetes (TCT2) — Children's Hospital Los Angeles, Los AngelesPhase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders — MD Anderson Cancer Center, HoustonComparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes — University Health System Texas Diabetic Institute, San AntonioSubclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease — Brigham and Women's Hospital, BostonDietary Insights and Nutritional Education in Adults on GLP-1 Therapy — University South Carolina, ColumbiaBalance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems — OrthoArizona--Mesa Arbor Avenue, MesaEvaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes — Sansum Diabetes Research Institute, Santa BarbaraStudy to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus — Lenzmeier Family Medicine, GlendaleContinuous Glucose Monitor Use in Pregnancy — University of Massachusetts Memorial Medical Center, WorcesterStudy to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN — GSK Investigational Site, BaltimoreUsing Virtual Reality to Improve Medical Training — Ohio University, AthensEnhancing Diabetes Care: Exposome &Amp; Sensors — University of Illinois - Chicago, ChicagoExtracellular Vesicles, Insulin Action, and Exercise — Institute for Food, Nutrition, and Health, New BrunswickThe Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD — National Institutes of Health Clinical Center, BethesdaPrimary Care Pragmatic, Real World Experience for Automated Insulin Delivery — University of Colorado Anschutz Medical Campus, AuroraPATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents — Children's Nutrition Research Center, HoustonThe Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes — Mayo Clinic in Rochester, RochesterDigital Health Navigation for Latino Patients With Type II Diabetes — Brigham and Women's Hospital, BostonA Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients — University of Alabama at Birmingham/ Children's of Alabama, BirminghamA Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 Diabetes — Clinical Pharmacology of Miami, MiamiFamilies Implementing Good Health Traditions for Life — Morehouse School of Medicine, AlbanyWearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity — Brooks Rehabilitation Center, JacksonvilleDeveloping and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes — University of California, San Diego, San DiegoRole of KATP Channel Loss in Type 2 Diabetes — Washington University in St. Louis, St LouisContinuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults — Scripps Health, San DiegoSafety of the Herpes Zoster Subunit Vaccine in Lupus — NYU Langone Health, New YorkFood and Fitness With Medicine (FFWM) — Ohio State Healthy Community Center, ColumbusGonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires — National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), BethesdaDirect to Patient Minimal Risk Biospecimen and Data Collection Research — Joined Bio, LexingtonA Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants — GSK Investigational Site, ScottsdaleA Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) — University Of Alabama, BirminghamRole of Autophagy in Type 2 Diabetes Microvascular Dysfunction — Medical College of Wisconsin, MilwaukeeAnifrolumab Pregnancy Study — Research Site, CaryA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease — Dermatology Research Associates - 300204025, Los AngelesA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Uni of Alabama at Birmingham, BirminghamSGLT2i, Pioglitazone, and Ketone Production in T2D — Texas Diabetes Institute/UH, San Antonio

Showing the 150 nearest — narrow your filters for fewer, closer studies.